RE: 4,593,539 shares issued30 Jun 2025 10:27
Any ideas what is going on with Patient three? On 3rd of June we had an RNS stating that ,'Manufacturing of HG-CT-1 for the treatment of a third patient is currently underway'. Nearly a month later now and no update. Is the patient not well enough to tolerate the treatment or have they deteriorated too much? Is there a manufacturing problem? Anyone know anything? I also though August and the Pharma conference would see enough patient data for interest to rise but I'm now thinking September or October.